CME GROUP INC.
CME GROUP INC. (CME) Stock News
The latest CME headlines and market coverage — 7 recent stories, updated throughout the day.
- Zacks Investment Research·
CME (CME) Upgraded to Buy: Here's Why
CME Group has received an upgrade to Zacks Rank #2 (Buy) based on upward revisions in earnings estimates. The company, which operates the Chicago Board of Trade and other exchanges, is expected to earn $12.34 per share for fiscal year 2026. Analysts have steadily raised their consensus estimates over the past three months, with a 0.6% increase, positioning CME in the top 20% of Zacks-covered stocks for estimate revisions.
- The Motley Fool·
CME vs. Mastercard: Which Financial Stock Is a Better Buy in 2026?
CME Group and Mastercard are compared as investment options for 2026. CME dominates derivatives trading with a 62% net margin, lower valuation (P/E 25.3x), and minimal debt (0.1x debt-to-equity), but faces volatile growth averaging 9.5%. Mastercard powers global payments with consistent 14.3% revenue growth, strong free cash flow of $16.4B, but trades at a higher valuation (P/E 33.8x) with 2.5x debt-to-equity. The article suggests CME may appeal to value-focused investors, while Mastercard attracts growth-oriented ones.
- The Motley Fool·Neutral
CME vs. Coinbase Global: Which Financial Stock Is a Better Buy in 2026?
CME Group and Coinbase Global represent two different approaches to financial infrastructure. CME operates a high-margin derivatives marketplace with a 62% net margin and strong cash generation, while Coinbase scales rapidly in crypto trading but faces regulatory uncertainty. The author recommends CME due to its superior profitability, lower valuation multiple, dividend payment, and skepticism about crypto's fundamental value.
- Zacks Investment Research·
CME Group (CME) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
CME Group is expected to report Q3 2026 earnings of $2.96 per share (up 10.5% YoY) with revenues of $1.71 billion (up 11.4% YoY) on October 21. The company has a positive Earnings ESP of +1.56% combined with a Zacks Rank #3, suggesting a likely earnings beat. CME has beaten consensus estimates in 3 of the last 4 quarters.
- The Motley Fool·
CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?
CME Group and Morningstar are compared as financial infrastructure plays. CME dominates derivatives trading with an impressive 62% net margin and $6.5B revenue, but trades at a premium valuation (forward P/E 22.5). Morningstar offers investment research with lower margins (15.3%) but more attractive valuation (forward P/E 15.5). The author leans toward CME despite valuation concerns due to its superior profitability and dividend, though both stocks have underperformed the S&P 500 over longer periods.
- The Motley Fool·
CME Group Is Launching Elon Musk's Tesla and SpaceX Futures Contracts on July 27. Here's the Investment Case.
CME Group will launch single-stock futures contracts for Tesla and SpaceX on July 27, offering highly leveraged trading tools with up to 100x magnification. While these instruments carry significant risk with unlimited loss potential, they can be useful for experienced traders to hedge existing positions or make leveraged bets. Most retail investors should avoid these complex derivatives.
- CNBC·Neutral
CME Group's Terry Duffy to step down in 2027, CFO Lynne Fitzpatrick to become CEO
Duffy, 67, will transition to executive chairman effective March 1, 2027, the company said Wednesday.